❤️Conditions & CareFDA Approves Neladalkib for Previously Treated ALK-Positive Lung Cancer
The FDA has granted accelerated approval to neladalkib for advanced ALK-positive non-small cell lung cancer patients who have undergone prior treatments.
❤️Conditions & CareThe FDA has granted accelerated approval to neladalkib for advanced ALK-positive non-small cell lung cancer patients who have undergone prior treatments.
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.